CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 194 filers reported holding CLOVIS ONCOLOGY INC in Q1 2019. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $65,000 | -82.3% | 11,261 | -78.5% | 0.00% | -84.6% |
| Q1 2021 | $368,000 | -89.8% | 52,396 | -74.0% | 0.03% | -87.1% |
| Q4 2018 | $3,614,000 | +99.3% | 201,218 | +939.3% | 0.20% | +176.7% |
| Q2 2017 | $1,813,000 | -59.9% | 19,361 | -72.7% | 0.07% | -69.2% |
| Q1 2017 | $4,524,000 | +44.7% | 71,047 | +109.0% | 0.24% | +238.6% |
| Q3 2015 | $3,126,000 | +57.8% | 33,997 | +4.3% | 0.07% | +29.6% |
| Q3 2013 | $1,981,000 | – | 32,596 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $45,630,648,000 | 43.63% |
| EcoR1 Capital, LLC | 384,348 | $21,523,000 | 10.89% |
| Palo Alto Investors LP | 2,102,857 | $117,760,000 | 6.91% |
| NEA Management Company, LLC | 2,279,781 | $127,668,000 | 6.19% |
| Redmile Group, LLC | 721,632 | $40,411,000 | 4.40% |
| Opaleye Management Inc. | 140,000 | $7,840,000 | 3.96% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 790,555 | $44,271,000 | 2.63% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 339,327 | $19,002,000 | 2.31% |
| PFM Health Sciences, LP | 1,725,126 | $96,607,000 | 2.26% |
| HARBOURVEST PARTNERS LLC | 51,037 | $2,858,000 | 1.50% |